Year 2019 (53)

Edition nr. 9

New product form: Calcipotriol/betamethasone aerosol foam for psoriasis

Leo M.L. Stolk
Nr 9|2019 (53)|Page 86-90|New|doi: 10.35351/gebu.2019.9.17

Calcipotriol/betamethasone aerosol foam 0.05mg/g and 0.5 mg/g (Enstilar®) were registered in 2016 for the ‘local treatment of psoriasis vulgaris in adults’. The combination of calcipotriol and betamethasone has been in use for many years in prima ...

In short Read article

Treatment of actinic keratosis with 5-FU cream

Anton J.F.A. Kerst, Hein J.E.M. Janssens
Nr 9|2019 (53)|Page 81-85|New|doi: 10.35351/gebu.2019.9.16

Actinic keratosis is a skin disorder which occurs in about 30% of persons aged over 50 years (more commonly among men). The main causative factor is exposure to sunlight. If not treated, there is a risk of malignant degeneration. The risk of squa ...

In short Read article